Project Details
| Status | Active |
|---|---|
| Effective start/end date | 9/15/21 → 8/31/26 |
Funding
- Massachusetts General Hospital (U01 NS120901 AMD1)
- National Institute of Neurological Disorders and Stroke (U01 NS120901 AMD1)
NN111 - A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease
- Grebenciucova, Elena (PD/PI)
Project: Research project